Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2012

01-07-2012 | Article

The effect of diabetic control status on the clinical features of pulmonary tuberculosis

Authors: S. W. Park, J. W. Shin, J. Y. Kim, I. W. Park, B. W. Choi, J. C. Choi, Y. S. Kim

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2012

Login to get access

Abstract

The aim of this study was to determine whether control status of diabetes mellitus influences clinical and radiographic manifestations and treatment responses in patients with tuberculosis (TB). The medical records of 492 patients who started anti-TB medication between January 2005 and December 2009 were retrospectively reviewed. Diabetes was diagnosed in 124 patients (25.2%). Of these, 74 (59.7%) were uncontrolled (HbA1C ≥7.0), 25 (20.2%) were controlled (HbA1C <7.0), and HbA1C levels were not assessed in the remaining 25 (20.2%). There were no differences in clinical symptoms between diabetics and non-diabetics, regardless of diabetes control status. There were also no differences in radiographic findings or AFB results between controlled diabetics and non-diabetics. However, uncontrolled diabetics had more cavitary lesions (p = 0.008) and higher positive smear rates (p < 0.001) compared with non-diabetics. After adjustment for age, cavities and positive smears before initiation of treatment, uncontrolled diabetes was a significant risk factor for a positive sputum culture at 2 months (odds ratio, 4.316; 95% CI, 1.306–14.267; p = 0.017). Uncontrolled diabetics seem to have more cavities, higher positive smear rates and lack of culture conversion after two months of therapy. Therefore, TB patients with uncontrolled diabetes should be carefully managed and treated.
Literature
1.
go back to reference Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S, Drobniewski F (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332(7533):85–87PubMedCrossRef Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S, Drobniewski F (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332(7533):85–87PubMedCrossRef
2.
go back to reference Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152PubMedCrossRef Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152PubMedCrossRef
3.
go back to reference Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M (2001) Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 68(6):595–600PubMedCrossRef Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M (2001) Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 68(6):595–600PubMedCrossRef
4.
go back to reference Berger G, Zuleger F (1951) Diabetes mellitus and pulmonary tuberculosis in the postwar years. Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin 6(2):66–80PubMed Berger G, Zuleger F (1951) Diabetes mellitus and pulmonary tuberculosis in the postwar years. Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin 6(2):66–80PubMed
5.
go back to reference Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, Huang MS (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 137(2):203–210PubMedCrossRef Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, Huang MS (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 137(2):203–210PubMedCrossRef
6.
go back to reference Weaver RA (1974) Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients. Am Rev Respir Dis 109(1):162–163PubMed Weaver RA (1974) Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients. Am Rev Respir Dis 109(1):162–163PubMed
7.
go back to reference Hadlock FP, Park SK, Awe RJ, Rivera M (1980) Unusual radiographic findings in adult pulmonary tuberculosis. AJR Am J Roentgenol 134(5):1015–1018PubMed Hadlock FP, Park SK, Awe RJ, Rivera M (1980) Unusual radiographic findings in adult pulmonary tuberculosis. AJR Am J Roentgenol 134(5):1015–1018PubMed
8.
go back to reference Segarra F, Sherman DS, Rodriguez-Aguero J (1963) Lower lung field tuberculosis. Am Rev Respir Dis 87:37–40PubMed Segarra F, Sherman DS, Rodriguez-Aguero J (1963) Lower lung field tuberculosis. Am Rev Respir Dis 87:37–40PubMed
9.
go back to reference Guler M, Unsal E, Dursun B, Aydln O, Capan N (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235PubMedCrossRef Guler M, Unsal E, Dursun B, Aydln O, Capan N (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235PubMedCrossRef
10.
go back to reference Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79PubMed Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79PubMed
11.
go back to reference Restrepo BI, Fisher-Hoch SP, Smith B, Jeon S, Rahbar MH, McCormick JB (2008) Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544PubMed Restrepo BI, Fisher-Hoch SP, Smith B, Jeon S, Rahbar MH, McCormick JB (2008) Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544PubMed
12.
go back to reference Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435PubMedCrossRef Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435PubMedCrossRef
13.
go back to reference Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639PubMed Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639PubMed
14.
go back to reference Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H (2007) Tuberculosis susceptibility of diabetic mice. Am J Res Cell Mol Biol 37(5):518–524CrossRef Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H (2007) Tuberculosis susceptibility of diabetic mice. Am J Res Cell Mol Biol 37(5):518–524CrossRef
15.
go back to reference Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, Cortes-Penfield N, McCormick JB (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641PubMedCrossRef Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, Cortes-Penfield N, McCormick JB (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641PubMedCrossRef
16.
go back to reference Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494PubMedCrossRef Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494PubMedCrossRef
17.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553PubMedCrossRef Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553PubMedCrossRef
18.
go back to reference Summary of revisions for the 2010 Clinical Practice Recommendations (2010) Diabetes Care 33(Suppl 1):S3 Summary of revisions for the 2010 Clinical Practice Recommendations (2010) Diabetes Care 33(Suppl 1):S3
19.
go back to reference Leung EC, Leung CC, Tam CM (2007) Delayed presentation and treatment of newly diagnosed pulmonary tuberculosis patients in Hong Kong. Hong Kong Med J 13(3):221–227PubMed Leung EC, Leung CC, Tam CM (2007) Delayed presentation and treatment of newly diagnosed pulmonary tuberculosis patients in Hong Kong. Hong Kong Med J 13(3):221–227PubMed
20.
go back to reference Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R (2000) Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 49(9):1451–1458PubMedCrossRef Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R (2000) Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 49(9):1451–1458PubMedCrossRef
21.
go back to reference MacRury SM, Gemmell CG, Paterson KR, MacCuish AC (1989) Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 42(11):1143–1147PubMedCrossRef MacRury SM, Gemmell CG, Paterson KR, MacCuish AC (1989) Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 42(11):1143–1147PubMedCrossRef
22.
go back to reference Sugawara I, Yamada H, Mizuno S (2004) Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204(2):135–145PubMedCrossRef Sugawara I, Yamada H, Mizuno S (2004) Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204(2):135–145PubMedCrossRef
23.
go back to reference Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, Nelwan RH, Netea MG, van Crevel R (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27(2):97–103PubMedCrossRef Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, Nelwan RH, Netea MG, van Crevel R (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27(2):97–103PubMedCrossRef
24.
go back to reference Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Anuar AK (2005) Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J Trop Med Public Health 36(Suppl 4):213–220PubMed Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Anuar AK (2005) Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J Trop Med Public Health 36(Suppl 4):213–220PubMed
25.
go back to reference Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, McCormick JB (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 135(3):483–491PubMedCrossRef Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, McCormick JB (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 135(3):483–491PubMedCrossRef
26.
go back to reference Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI (2008) Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 40(11–12):888–893PubMedCrossRef Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI (2008) Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 40(11–12):888–893PubMedCrossRef
27.
go back to reference Sosman MC, Steidl JH (1927) Diabetic tuberculosis. Am J Roentgenol 17:625–629 Sosman MC, Steidl JH (1927) Diabetic tuberculosis. Am J Roentgenol 17:625–629
28.
go back to reference Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO, Shaikh MA (2003) Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 7(1):58–64PubMed Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO, Shaikh MA (2003) Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 7(1):58–64PubMed
29.
go back to reference Wang JY, Lee LN, Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 9(7):777–783PubMed Wang JY, Lee LN, Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 9(7):777–783PubMed
30.
go back to reference Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201PubMed Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201PubMed
31.
go back to reference Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242PubMedCrossRef Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242PubMedCrossRef
32.
go back to reference Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, Saito A (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64PubMedCrossRef Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, Saito A (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64PubMedCrossRef
33.
go back to reference Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT (2001) Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther 69(6):400–406PubMedCrossRef Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT (2001) Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther 69(6):400–406PubMedCrossRef
Metadata
Title
The effect of diabetic control status on the clinical features of pulmonary tuberculosis
Authors
S. W. Park
J. W. Shin
J. Y. Kim
I. W. Park
B. W. Choi
J. C. Choi
Y. S. Kim
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1443-3

Other articles of this Issue 7/2012

European Journal of Clinical Microbiology & Infectious Diseases 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine